Minesh Mehta
Miami Cancer Institute at Baptist Health, Inc. · Miami Cancer Institute, Miami FL USA · University of Marylannd School of Medicine
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Minesh Mehta as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 23:36 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT05789589 · Effect of Azeliragon Combined With Stereotactic Radiation Therapy in Patients With Brain MetastasesBaptist Health South Florida · suspended · Cancer, Metastasis, Metastatic Cancer · principal investigator
- Ph3NCT02831959 · Pivotal, Open-label, Randomized Study of Radiosurgery With or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases From Non-small Cell Lung Cancer (NSCLC).NovoCure GmbH · completed · Brain Metastases From Non-small Cell Lung Cancer (NSCLC) · principal investigator
- Ph2NCT01778088 · Open-Label Study of I-131-CLR1404 in Subjects With Recurrent GliomaCellectar Biosciences, Inc. · withdrawn · Glioma · principal investigator
- N/ANCT00585819 · Validation of a Novel Thoracic Neoplasm Radiotherapy Image Guidance Technique: A Pilot StudyUniversity of Wisconsin, Madison · withdrawn · Lung Cancer · principal investigator
- Ph1NCT00003909 · Motexafin Gadolinium Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem GliomaNational Cancer Institute (NCI) · completed · Untreated Childhood Brain Stem Glioma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-11 23:36 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- NABTC (UCSF PROJECT LEADER) U OF WISCONSINU01CA062421 · NCI · UNIVERSITY OF WISCONSIN-MADISON · fiscal years 1994 to 2008 · $122,873 awarded in 2008Same name and institution; not confirmed by an ID
- PHASE II STUDY OF XRT + LOW-DOSE TEMOZOLOMIDE FOLLOWED BY TEMOZOLOMIDE + CPT-11M01RR003186 · NCRR · UNIVERSITY OF WISCONSIN-MADISON · fiscal years 1998 to 2007 · $949 awarded in 2007Same name and institution; not confirmed by an ID
- Improving Cancer Outcome--Adaptive Helical TomotherapyP01CA088960 · NCI · UNIVERSITY OF WISCONSIN-MADISON · fiscal years 2001 to 2005 · $1,844,141 awarded in 2005Same name and institution; not confirmed by an ID
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Children's Oncology Group Phase 1 / Pilot ConsortiumU01CA097452 · NCI · NATIONAL CHILDHOOD CANCER FOUNDATION · PI SUSAN M. BLANEY · fiscal years 2002 to 2011Named on NCT00003909
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-11 23:36 UTC. The ranking covers the 200 most relevant of 287 PubMed records, and a shared surname and initials can bring in a namesake. All 287 on PubMed
- A randomized trial of bevacizumab for newly diagnosed glioblastoma.N Engl J Med · 20142,246 citationsRCR 69.8
- 1,838 citationsRCR 45.9
- 883 citationsRCR 30.5
- Dose-dense temozolomide for newly diagnosed glioblastoma: a randomized phase III clinical trial.J Clin Oncol · 2013843 citationsRCR 26.0
- Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402.J Clin Oncol · 2013833 citationsRCR 25.6
- A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database.Int J Radiat Oncol Biol Phys · 2008805 citationsRCR 20.1
- Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma.N Engl J Med · 2016803 citationsRCR 29.8
- Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial.Neuro Oncol · 2013729 citationsRCR 22.7
- Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001.J Clin Oncol · 2020700 citationsRCR 35.2
- Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: report of Radiation Therapy Oncology Group 93-05 protocol.Int J Radiat Oncol Biol Phys · 2004396 citationsRCR 10.2